Mu-type opioid receptor
Also known as: MOR1, OPRM1
Function
Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone. Also activated by enkephalin peptides, such as Met-enkephalin or Met-enkephalin-Arg-Phe, with higher affinity for Met-enkephalin-Arg-Phe (By similarity). Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G protein complex and subsequent exchange of GDP for GTP in the G protein alpha subunit leading to dissociation of the G protein complex with the free GTP-bound G protein alpha and the G protein beta-gamma dimer activating downstream cellular effectors. The agonist- and cell type-specific activity is predominantly coupled to pertussis toxin-sensitive G(i) and G(o) G alpha proteins, GNAI1, GNAI2, GNAI3 and GNAO1 isoforms Alpha-1 and Alpha-2, and to a lesser extent to pertussis toxin-insensitive G alpha proteins GNAZ and GNA15. They mediate an array of downstream cellular responses, including inhibition of adenylate cyclase activity and both N-type and L-type calcium channels, activation of inward rectifying potassium channels, mitogen-activated protein kinase (MAPK), phospholipase C (PLC), phosphoinositide/protein kinase (PKC), phosphoinositide 3-kinase (PI3K) and regulation of NF-kappa-B (By similarity). Also couples to adenylate cyclase stimulatory G alpha proteins (By similarity). The selective temporal coupling to G proteins and subsequent signaling can be regulated by RGSZ proteins, such as RGS9, RGS17 and RGS4 (By similarity). Phosphorylation by members of the GPRK subfamily of Ser/Thr protein kinases and association with beta-arrestins is involved in short-term receptor desensitization (By similarity). Beta-arrestins associate with the GPRK-phosphorylated receptor and uncouple it from the G protein thus terminating signal transduction (By similarity). The phosphorylated receptor is internalized through endocytosis via clathrin-coated pits which involves beta-arrestins (By similarity). The activation of the ERK pathway occurs either in a G protein-dependent or a beta-arrestin-dependent manner and is regulated by agonist-specific receptor phosphorylation (By similarity). Acts as a class A G protein-coupled receptor (GPCR) which dissociates from beta-arrestin at or near the plasma membrane and undergoes rapid recycling (By similarity). Receptor down-regulation pathways are varying with the agonist and occur dependent or independent of G protein coupling (By similarity). Endogenous ligands induce rapid desensitization, endocytosis and recycling (By similarity). Heterooligomerization with other GPCRs can modulate agonist binding, signaling and trafficking properties (By similarity).
Classification
- Family (Pfam)
- PF00001 7tm_1
- InterPro
- GPCR_Rhodpsn, GPCR_Rhodpsn_7TM, Mu_opioid_rcpt, Opioid_rcpt
- Functional cluster
- Membrane Transporters & GPCRs
Experimental structures · PDB · 24
- 8EF5 EM 3.30A
- 8EF6 EM 3.20A
- 8EFB EM 3.20A
- 8EFL EM 3.20A
- 8EFO EM 2.80A
- 8EFQ EM 3.30A
- 8F7Q EM 3.22A
- 8F7R EM 3.28A
- 8K9K EM 2.98A
- 8K9L EM 3.05A
- 8Y72 EM 2.65A
- 8Y73 EM 2.84A
- … and 12 more
A predicted model is available from AlphaFold.
Gene Ontology · 34
- GO:0030424 axon
- GO:0030425 dendrite
- GO:0005783 endoplasmic reticulum
- GO:0005768 endosome
- GO:0005794 Golgi apparatus
- GO:0043005 neuron projection
- GO:0043204 perikaryon
- GO:0005886 plasma membrane
- GO:0045202 synapse
- GO:0004979 beta-endorphin receptor activity
- GO:0004930 G protein-coupled receptor activity
- GO:0001965 G-protein alpha-subunit binding
- GO:0031681 G-protein beta-subunit binding
- GO:0038047 morphine receptor activity
- GO:0042923 neuropeptide binding
- GO:0005245 voltage-gated calcium channel activity
- GO:0007197 adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway
- GO:0007193 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- GO:0048149 behavioral response to ethanol
- GO:0038003 G protein-coupled opioid receptor signaling pathway
- GO:0007186 G protein-coupled receptor signaling pathway
- GO:0007187 G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
- GO:0008285 negative regulation of cell population proliferation
- GO:0051481 negative regulation of cytosolic calcium ion concentration
- GO:0045019 negative regulation of nitric oxide biosynthetic process
- GO:0061358 negative regulation of Wnt protein secretion
- GO:0007218 neuropeptide signaling pathway
- GO:0007200 phospholipase C-activating G protein-coupled receptor signaling pathway
- GO:0070374 positive regulation of ERK1 and ERK2 cascade
- GO:0050769 positive regulation of neurogenesis
- GO:0080135 regulation of cellular response to stress
- GO:2000310 regulation of NMDA receptor activity
- GO:0007600 sensory perception
- GO:0019233 sensory perception of pain
Drugs targeting this protein · 67
- ALFENTANIL HYDROCHLORIDE agonist
- ANILERIDINE PHOSPHATE agonist
- DIFENOXIN HYDROCHLORIDE agonist
- DIPHENOXYLATE HYDROCHLORIDE agonist
- OXYMORPHONE HYDROCHLORIDE agonist
- LEVOMETHADYL ACETATE HYDROCHLORIDE agonist
- METHADONE HYDROCHLORIDE agonist
- OXYCODONE HYDROCHLORIDE agonist
- ANILERIDINE HYDROCHLORIDE agonist
- REMIFENTANIL HYDROCHLORIDE agonist
- NALBUPHINE HYDROCHLORIDE agonist
- NALTREXONE HYDROCHLORIDE antagonist
- FENTANYL HYDROCHLORIDE agonist
- SUFENTANIL CITRATE agonist
- METHYLNALTREXONE BROMIDE antagonist
- TAPENTADOL HYDROCHLORIDE agonist
- HYDROMORPHONE HYDROCHLORIDE agonist
- TRAMADOL HYDROCHLORIDE agonist
- PROPOXYPHENE HYDROCHLORIDE agonist
- LEVOMETHADYL ACETATE agonist
- DEZOCINE partial agonist
- MEPERIDINE HYDROCHLORIDE agonist
- LOPERAMIDE HYDROCHLORIDE agonist
- NALOXONE HYDROCHLORIDE antagonist
- NALTREXONE antagonist
- DIHYDROCODEINE BITARTRATE agonist
- LEVALLORPHAN TARTRATE antagonist
- MORPHINE SULFATE agonist
- FAXELADOL agonist
- ONDELOPRAN antagonist
- SAMIDORPHAN L-MALATE antagonist
- NALDEMEDINE antagonist
- ELUXADOLINE agonist
- NALOXEGOL OXALATE antagonist
- CEBRANOPADOL agonist
- METHYLSAMIDORPHAN antagonist
- BUPRENORPHINE HYDROCHLORIDE agonist
- OLICERIDINE agonist
- ALVIMOPAN antagonist
- BUTORPHANOL TARTRATE partial agonist
- NALDEMEDINE TOSYLATE antagonist
- BEVENOPRAN antagonist
- BENZHYDROCODONE HYDROCHLORIDE agonist
- AXELOPRAN antagonist
- MEPTAZINOL partial agonist
- CP-866087 antagonist
- NALTALIMIDE partial agonist
- DEXTROMORAMIDE agonist
- FRAKEFAMIDE agonist
- HYDROCODONE BITARTRATE agonist
- AXOMADOL agonist
- PROPOXYPHENE NAPSYLATE agonist
- LEVORPHANOL TARTRATE agonist
- OXYCODONE TEREPHTHALATE agonist
- SAMIDORPHAN antagonist
- CODEINE SULFATE agonist
- GSK-1521498 antagonist
- OXYCODEGOL agonist
- DIACETYLMORPHINE agonist
- ORP-101 partial agonist
- BUPRENORPHINE agonist
- NALMEFENE HYDROCHLORIDE DIHYDRATE antagonist
- NALOXONE HYDROCHLORIDE DIHYDRATE antagonist
- FENTANYL agonist
- CODEINE PHOSPHATE agonist
- OXYCODONE agonist
- FENTANYL CITRATE agonist
Related proteins · sequence + function similarity
- Mu-type opioid receptor 1.00
- Mu-type opioid receptor 1.00
- Mu-type opioid receptor 1.00
- Mu-type opioid receptor 0.99
- Mu-type opioid receptor 0.99
- Mu-type opioid receptor 0.99
- Mu-type opioid receptor 0.99
- Mu-type opioid receptor 0.99
- Kappa-type opioid receptor 0.96
- Kappa-type opioid receptor 0.96
- Kappa-type opioid receptor 0.95
- Kappa-type opioid receptor 0.95
Co-cited proteins · studied together in the literature
- DnaJ homolog subfamily B member 4 1 shared papers
- Mu-type opioid receptor 1 shared papers
Literature · 33 cited papers
- A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism. Mol. Pain · 2010
- Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence. BMC Neurosci. · 2010
- Regulation of mu opioid receptor internalization by the scaffold protein RanBPM. Neurosci. Lett. · 2009
- Membrane functional organisation and dynamic of mu-opioid receptors. Cell. Mol. Life Sci. · 2009
- Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum. Mol. Genet. · 2009
- Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene. J. Neurochem. · 2009
- Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity. J. Biol. Chem. · 2007
- The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor. Biochem. Biophys. Res. Commun. · 2006
- A member of the heat shock protein 40 family, hlj1, binds to the carboxyl tail of the human mu opioid receptor. Brain Res. · 2006
- Functional complementation and the analysis of opioid receptor homodimerization. Mol. Pharmacol. · 2005
- Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm. Neuroscience · 2005
- Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer. Mol. Pharmacol. · 2005
- … and 21 more in the literature graph